MedTrace Logo

The Exploratory Clinical Trials for the Feasibility, Primary Safety and Efficacy of Foldable Capsular Vitreous Body

NCT00910702 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2013-04-30

No results posted yet for this study

Summary

The purpose of this study is to determine the feasibility, primary safety and efficacy of foldable capsular vitreous body (FCVB) in the treatment of retinal detachment.

Conditions

  • Retinal Detachment

Interventions

DEVICE

foldable capsular vitreous body(FCVB)

the vitreous cavity is tamponaded with the foldable capsular vitreous body (FCVB) after PPV

Sponsors & Collaborators

  • Sun Yat-sen University

    collaborator OTHER

  • GuangZhou WeiShiBo Biotechnology Co., ltd

    lead INDUSTRY

Principal Investigators

  • Qianying Gao, MD,Ph.D · Zhongshan Ophthalmic Center, Sun Yat-sen University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
10 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2012-12-31
Completion
2013-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00910702 on ClinicalTrials.gov